|Bid||97.50 x 800|
|Ask||97.09 x 900|
|Day's Range||96.98 - 101.72|
|52 Week Range||96.98 - 136.48|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||11.36|
|Earnings Date||Feb 09, 2022 - Feb 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||124.11|
Subscribe to Yahoo Finance Plus to view Fair Value for DVALearn more
AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.
Wolf Haldenstein Adler Freeman & Herz LLP, a preeminent national consumer rights law firm, is investigating claims on behalf of patients of VillageHealth and Da Vita, Inc. whose information may be have stolen in a recent data breach. PracticeMax, a vendor of VillageHealth and Da Vita, is notifying patients that their personal information, including names, addresses, dates of birth, clinical data, and Social Security Numbers may have been stolen as part of a recent hack.
DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology (ASN) Kidney Week occurring Nov. 4–7, 2021.